Open AccessImmunotherapy Regimens Improve Esophageal Cancer Survival
Author(s) -
Mark L. Fuerst
Publication year - 2021
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000767460.39903.b8
Subject(s) - medicine , nivolumab , oncology , chemotherapy , esophageal cancer , regimen , ipilimumab , immunotherapy , cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom